A connected decision platform that standardizes clinical and financial data for biotech investors, turning fragmented portfolio updates into real-time valuations and capital decisions.
Problem
Biotech investors make high-stakes capital decisions using fragmented spreadsheets, lagging clinical trial updates, and inconsistent data formats. By the time numbers are reconciled across portfolio assets, critical decision windows have passed.
Solution
A single platform that automatically validates and standardizes company submissions into connected analytical models. Investment teams can stress-test clinical trial success, burn rates, and market assumptions with instant recalculation across valuations, runway, and IPO readiness.
Benefits
Status
Interactive POC / Demo Available
Let's Rethink How Your Firm Works.
We don't just implement tools – we help advisory services leaders rethink how they work, so they can focus on what matters: serving clients, empowering teams, and staying human in an automated world.
If you're looking for a partner who combines rigor with heart – and who still gets genuinely excited about a good business idea
Talk To An Advisor →
